ArticleOncotarget2017

Synergistic inhibitory effects of deferasirox in combination with decitabine on leukemia cell lines SKM-1, THP-1, and K-562.

Nianyi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.